Author

A. M. Delahoussaye

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:host-pathogen & immune response· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

C. M. Taniguchi· 2 shared T. N. Fujimoto· 2 shared A. Deorukhkar· 1 shared A. Maitra· 1 shared C. J. G. Garcia· 1 shared C. J. Garcia Garcia· 1 shared D. Lin· 1 shared D. Saur· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. M. Taniguchi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivSep 8, 2021

Feasibility of Administering Human Pancreatic Cancer Chemotherapy in a Spontaneous Pancreatic Cancer Mouse Model

A. M. Delahoussaye, J. A. Jaoude, T. N. Fujimoto…·C. M. Taniguchi

This study demonstrates the feasibility of administering clinical chemotherapy regimens, mFOLFIRINOX and gemcitabine/nab-paclitaxel, in a spontaneous pancreatic cancer mouse model, showing improved survival compared to controls.

DOI 10.1186/s12885-022-09255-3

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 21, 2021

Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment

Y. Huang, C. J. Garcia Garcia, D. Lin…·C. M. Taniguchi

This study shows that deleting HIF2 in cancer-associated fibroblasts reduces pancreatic tumor growth and immunosuppression, suggesting HIF2 as a therapeutic target.

DOI 10.1101/2021.05.21.445190

mousebulk RNA-seq

𝕏 PostBluesky